TrialEuropean journal of heart failure2016

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial.

Orly Vardeny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.